<?xml version="1.0" encoding="UTF-8"?>
<p id="p0235">Owing to the vast number of cytokines provoked by SARS, MERS, and SARS-CoV-2, corticosteroids were used regularly for critical case management, aiming to reduce the inflammation and influence pulmonary damage. Still, contemporary data in SARS and MERS cases implies no benefit of corticosteroid on mortality rather than prolonged viral clearing 
 <xref rid="b0080" ref-type="bibr">[16]</xref>. Intravenous methylprednisolone has been used supportively in ECoV neurological cases 
 <xref rid="b0300" ref-type="bibr">[60]</xref>. Massive intravenous corticosteroid dosages may influence CIM. Hence, to limit CIM, avoiding corticosteroid treatment is recommended 
 <xref rid="b0285" ref-type="bibr">[57]</xref>, 
 <xref rid="b0395" ref-type="bibr">[79]</xref>.
</p>
